See how top analysts and institutions rate ARM — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Seaport Research Partners | Initiated | Buy | $150 | 2025-08-11 |
| TD Cowen | Reiterated | Buy | $155 → $175 | 2025-07-31 |
| BNP Paribas Exane | Upgrade | Neutral → Outperform | $210 | 2025-07-16 |
| Goldman | Initiated | Neutral | $160 | 2025-07-10 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 16 | 14 | 3 | 0 |
| October 2025 | 5 | 16 | 14 | 3 | 0 |
| September 2025 | 5 | 17 | 13 | 3 | 1 |
| August 2025 | 5 | 17 | 13 | 3 | 1 |
The majority of institutional investors have issued a "Buy" rating for ARM, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
